JUN 24, 2019 2:36 PM PDT

Drug Combination May Combat Deadly Drug-Resistant Fungus

WRITTEN BY: Nouran Amin

A drug combination of anti-fungal and anti-bacterial medications may be effective against the spread of a highly infectious and deadly fungus--Candida auris (C. auris). According to the Centers for Disease and Control, C. auris was first discovered in Japan and has affected individuals in more than 20 countries and sickened 643 Americans in 11 U.S. states. The fungus has baffled health officials as the search for treatment options are higher than ever.

"Few treatment options are available for patients infected with Candida auris, which causes invasive, life-threatening infections, usually in patients who are already critically ill or have compromised immune systems," said Brennan-Krohn, MD, a post-doctoral research fellow in the lab of James E. Kirby, MD, Director of the Clinical Microbiology Laboratory at BIDMC. "It has an alarming propensity to spread from patient to patient and survive on surfaces in rooms, resulting in hospital outbreaks."

Findings presented at the annual meeting of the American Society for Microbiology discuss how the search for new treatment approaches allowed researchers to use a modified inkjet printer. The modified inkjet printer allows for rapid and uniform antimicrobial screening for the testing of antifungal drugs, amphotericin and caspofungin, in combination with two antibacterial antibiotics antibiotics, minocycline and rifampin,—to maximize the efficacy against fungal infections. Results showed three new combinations of antifungal and antibacterial drugs that demonstrated effectiveness against C. auris.

Although the dugs have not been tested in combination in C. auris-infected humans, the drugs are actually FDA-approved and presently prescribed for patients with a variety of infections.

However, if the drugs prove to eradicate C. auris infections in clinical studies, then physicians already have access to the effective treatment for their patients infected with C. auris.

Source: Science Daily

About the Author
Master's (MA/MS/Other)
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
DEC 05, 2022
Drug Discovery & Development
Characterization and Manufacturing of AAVs for Gene Therapy
Characterization and Manufacturing of AAVs for Gene Therapy
The backdrop upon which every successful gene therapy is developed is the ability to safely and specifically target cell ...
NOV 30, 2022
Neuroscience
Study Shows a High Rate of Negative Effects of Ayahuasca
Study Shows a High Rate of Negative Effects of Ayahuasca
A new study published in PLOS Global Public Health found a high rate of adverse physical and psychological effects from ...
DEC 01, 2022
Cannabis Sciences
Study Finds CBD Does Not Reduce the Psychoactive High Caused by THC
Study Finds CBD Does Not Reduce the Psychoactive High Caused by THC
Researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London found ...
DEC 27, 2022
Drug Discovery & Development
Blood Pressure Drug and Antioxidant May Treat Long COVID Brain Fog
Blood Pressure Drug and Antioxidant May Treat Long COVID Brain Fog
Two FDA-approved drugs mitigate and may even eliminate brain fog in people with long COVID. The corresponding case repor ...
JAN 05, 2023
Health & Medicine
A noninvasive sleep sensor that could prevent opioid overdose in recovering patients
A noninvasive sleep sensor that could prevent opioid overdose in recovering patients
Opioid Use Disorder (OUD) is a chronic condition of opioid use that results in significant distress, dependence, relapse ...
JAN 22, 2023
Neuroscience
Research Study Explores the Mysterious Causes of Pediatric Epilepsy
Research Study Explores the Mysterious Causes of Pediatric Epilepsy
Childhood epilepsy affects roughly 4% of the pediatric population, and there are many different types of epilepsy and se ...
Loading Comments...